10-Q: UMeWorld Q4 Loss Widens on China Expansion, Liquidity Doubt

UMeWorld Inc. reported a significantly increased net loss for Q4 2025 despite a surge in revenue driven by its new China operations, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net loss for the three months ended December 31, 2025, was $138,727, a significant increase from $14,710 in the prior-year quarter.
• Revenue surged to $147,455 for the quarter, up from $195 in the same period last year, primarily due to an initial distributor order in China.
• Gross profit was $4,542, compared to a gross loss of $2,388 in the prior-year quarter, but gross margin remained low.
• Operating expenses dramatically increased to $143,296 from $12,322, driven by professional fees, executive compensation, and corporate restructuring costs.
• The company had a working capital deficiency of $462,599 and an accumulated deficit of $32,068,371 as of December 31, 2025.
• Cash and cash equivalents decreased to $60,904 at December 31, 2025, from $154,353 at September 30, 2025.
• Inventory levels significantly increased to $1,682,509 from $13,410, primarily for Asia-Pacific sales.
• The company completed its redomiciliation to Delaware on October 2, 2025, and began limited sales activities in the Asia-Pacific region in December 2025.
• Disclosure controls and procedures were deemed ineffective due to deficiencies in internal control over financial reporting, with remediation efforts underway.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a highly concerning report. While revenue growth is positive, the significantly widened net loss, severe liquidity issues, and ineffective internal controls overshadow any operational progress, indicating substantial financial instability and high execution risk.

Positives

• Revenue increased significantly to $147,455 for the three months ended December 31, 2025, from $195 in the prior-year quarter, driven by new China operations.
• Achieved a gross profit of $4,542 for the quarter, reversing a gross loss of $2,388 in the same period last year.
• Successfully established an Asia-Pacific holding structure and commenced revenue-generating sales activities in China in December 2025.
• Completed redomiciliation to Delaware and transitioned to a U.S. domestic issuer for SEC reporting purposes on October 2, 2025.
• Related-party advances totaling $203,647 were converted into 814,588 shares of common stock on January 19, 2026, reducing related-party liabilities and increasing stockholders' equity.

Negatives

• Net loss significantly widened to $138,727 for the three months ended December 31, 2025, compared to $14,710 in the prior-year quarter.
• Operating expenses increased substantially to $143,296 from $12,322, primarily due to higher professional fees, executive compensation, and corporate/compliance costs.
• The company reported a working capital deficiency of $462,599 and an accumulated deficit of $32,068,371 as of December 31, 2025.
• Cash and cash equivalents decreased by $93,449 during the quarter, ending at $60,904.
• Net cash used in operating activities increased to $93,488 for the quarter, up from $53,254 in the prior-year period.
• Gross margin remained very low (approximately 3.1%), suggesting profitability issues despite increased sales volume.
• Disclosure controls and procedures were deemed ineffective due to deficiencies in internal control over financial reporting related to limited accounting personnel and segregation of duties.

Risks

• Substantial doubt about the company's ability to continue as a going concern due to recurring operating losses, an accumulated deficit of $32,068,371, and a working capital deficiency of $462,599.
• Reliance on a single specialized DAG oil supplier in China, increasing exposure to supply interruption and pricing risk, as this supplier accounted for approximately 99% of total cost of sales for the quarter.
• High customer concentration, with one distribution partner in China accounting for approximately 98% of total revenue for the quarter, posing a risk if future orders decrease or the relationship is lost.
• Geographic concentration of revenue, with approximately 98% of total revenue for the quarter generated from sales in China, making the company vulnerable to changes in economic conditions, regulatory environments, or trade policies in that region.
• Reliance on third-party manufacturers, co-packers, and logistics providers, where service interruptions, capacity limits, or cost increases could disrupt fulfillment and increase operating costs.
• Liquidity risk due to the need for additional capital to support operations, working capital, and business development activities, with no assurance that financing will be available on acceptable terms.
• Foreign currency exchange rate risk, particularly related to Renminbi-denominated transactions, although currently not considered material.
• Deficiencies in internal control over financial reporting related to limited accounting personnel and segregation of duties, which could adversely affect the company's ability to record, process, summarize, and report financial information.

Future Outlook

Management plans to pursue additional business arrangements and growth opportunities in the functional nutrition and health-and-wellness markets through Dagola, expand distribution channels and product offerings to increase revenues, and seek additional capital through promissory notes, private placements, and other financing transactions. The company expects inventory levels to fluctuate based on distributor demand, purchase timing, and logistics planning.

Management Comments

• Managements plans to alleviate this substantial doubt include: pursuing additional business arrangements and growth opportunities in the functional nutrition and health-and-wellness markets through Dagola; expanding distribution channels and product offerings to increase revenues; and seeking additional capital through promissory notes, private placements, and other financing transactions.
• There can be no assurance that these plans will be successful or that additional financing will be available on acceptable terms, or at all.
• Management expects inventory levels to fluctuate based on distributor demand, purchase timing, and logistics planning.
• The Company expects that it will need additional capital to support operations, working capital requirements, and business development activities.
• Management is evaluating financing alternatives, which may include related-party funding, private placements, and other capital raising transactions.
• Management has begun implementing remediation measures to address these control deficiencies, including adding accounting and financial reporting resources, enhancing supervisory review controls, and improving segregation of duties where practical.

Industry Context

StockSavvy.ai notes that UMeWorld's strategic pivot towards functional nutrition and DAG-based cooking oil aligns with growing global trends in health-and-wellness and specialized dietary products. The expansion into the Asia-Pacific market, particularly China, taps into a large and rapidly expanding consumer base for health-conscious food items. However, the reliance on a single distributor and supplier in this new market highlights significant concentration risks, which are common for smaller companies entering complex international markets but require careful management to ensure sustainable growth and mitigate potential disruptions. The move into renewable fuel initiatives, while pre-commercial, suggests a diversification strategy that could position the company in emerging green energy sectors, though it is currently outside its core functional nutrition business.

Comparison to Industry Standards

• UMeWorld's gross margin of approximately 3.1% ($4,542 gross profit on $147,455 revenue) is significantly lower than typical industry benchmarks for consumer packaged goods (CPG) or specialized food products, which often range from 20% to 50% or higher. For example, major CPG companies like Nestlé or Unilever typically report gross margins in the 30-50% range, while even smaller, specialized health food brands often aim for 25%+ to cover substantial marketing and R&D costs.
• The substantial increase in operating expenses (over 1000% year-over-year) relative to revenue growth, leading to a widened net loss, indicates a lack of operating leverage and significant investment in infrastructure and advisory services. This contrasts with more mature companies that demonstrate economies of scale as revenue grows.
• The working capital deficiency of $462,599 and accumulated deficit of $32,068,371 are indicative of a company in an early, high-burn growth phase or facing severe financial distress, far from the healthy liquidity positions seen in established industry players.
• The high concentration of revenue (98% from one distributor in China) and cost of sales (99% from one supplier) is atypical for a diversified CPG company and represents a much higher risk profile compared to industry leaders who typically have broad distribution networks and multiple suppliers to mitigate supply chain and market risks.

Corporate Governance

Legal Proceedings

• The company is not a party to any material legal proceedings.
• Management does not believe that the resolution of any ordinary course claims would have a material adverse effect on the company's financial condition, results of operations, or cash flows.

Related Party Transactions

• Ownership of Dagola Hong Kong Limited and its wholly owned PRC subsidiary, Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd., was transferred from the Chief Executive Officer to the Company in October 2025.
• Amounts due to related parties (Michael Lee, Ford Moore, First Scion Investments Limited) totaled $329,863 as of December 31, 2025, representing non-trade advances, unpaid compensation, and expense reimbursements.
• On January 19, 2026, Michael Lee (CEO) converted $154,647 of advances into 618,588 shares of common stock.
• On January 19, 2026, Ford Moore (Director) converted $49,000 of advances into 196,000 shares of common stock.
• On January 16, 2026, Verdant Sustainable Fuel Sdn. Bhd., initially formed by the CEO, was transferred to the Company, becoming a wholly owned subsidiary.

Stakeholder Impact

• Shareholders face significant dilution risk from potential future capital raises and the conversion of related-party debt to equity. The substantial doubt about going concern and widening net loss pose a direct threat to investment value.
• Employees' job security and future growth opportunities could be impacted by the company's financial instability and reliance on external financing.
• Customers may experience supply disruptions or inconsistent product availability if the highly concentrated distribution relationship in China falters.
• Suppliers, particularly the single DAG oil supplier, face dependency risks and potential for supply chain disruptions or increased costs, which could affect product availability and pricing.
• Creditors, including related parties, face elevated risk due to the overall working capital deficiency and going concern warning, despite some related-party advances being converted to equity.

Next Steps

• Pursue additional business arrangements and growth opportunities in the functional nutrition and health-and-wellness markets through Dagola.
• Expand distribution channels and product offerings to increase revenues.
• Seek additional capital through promissory notes, private placements, and other financing transactions.
• Continue implementing remediation measures to address deficiencies in internal control over financial reporting, including adding accounting and financial reporting resources, enhancing supervisory review controls, and improving segregation of duties.
• Evaluate early-stage activities related to renewable fuel and sustainable aviation fuel feedstock initiatives through Verdant Sustainable Fuel Sdn. Bhd.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a substantial net loss, significant working capital deficiency, and a going concern warning. While revenue growth is notable, it is driven by a highly concentrated customer base and supplier, introducing extreme operational risks. The ineffective internal controls further compound governance concerns. The need for continuous external financing and the conversion of related-party debt to equity signal a desperate financial situation, making the stock a high-risk, speculative investment with a strong likelihood of further value erosion.

Keywords

Functional Nutrition, DAG-based cooking oil, DAGola, Health and Wellness, SEC 10-Q, Quarterly Report, UMeWorld Inc., China market, E-commerce, Distribution channels, Going concern, Related party transactions, Corporate governance, Supply chain risk, Financial performance, Delaware redomiciliation, OTC Markets, UMEW